Search company, investor...

Predict your next investment

Asset/Investment Management

Investments

17

Portfolio Exits

4

About Holden Capital

Holden Capital is an asset management firm.

Headquarters Location

Greenwich, Connecticut, 06830,

United States

Want to inform investors similar to Holden Capital about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Latest Holden Capital News

Holden Capital Partners seeking to grow broker network

Mar 17, 2023

Latest News Company offers commercial finance for developments Holden Capital Partners’ new head of brokerage, Callum Short, said one of his core aims will be to spearhead growth in the specialist non-bank lender’s broker network over the next one to two years. With a focus on commercial finance for developer clients, Holden Capital Partners has grown out of the southeast Queensland market to service the broader eastern seaboard over the last five years. Short (pictured above) said although the company had “a solid base of brokers nationally”, it would look to expand its introducer network across Australia, with a particular focus on Brisbane, Sydney and Melbourne. “We value the role brokers play in our business and for our clients – they are really integral to the transaction, and integral to the deal flow and growth of our business,” Short said. “We have a solid range of brokers throughout the country and the plan is to expand our referral network and broker network continually and significantly over the next two years.” Commercial finance for development deals Short said development finance was an “interesting landscape” at the moment, with an economic environment that included both rising interest rates and increasing construction prices . Holden Capital Partners is focusing on deals such as land subdivisions, residential luxury builds and townhouse projects, and staying away from larger scale multi-residential developments. “We are seeing loans with a time frame of six to 18 months as really being the sweet spot for us.” Short said as COVID-19 ended, the market had seen the benefit of rising gross realisations on projects, and the ability of a lot of projects “to get out of the ground without too many disruptions”. However he said now deals were slightly more constrained deals in terms of gross realisations. “Sponsors and developers are needing to stay much more on top of what the market is to make sure everything is stacking up compared with 12 months ago.” Appetite from investors still strong Holden Capital Partners is set to settle over $50 million across 10 transactions in the first quarter of 2023. Since 2017, it has completed loan facilities exceeding $250m across more than 70 projects. During that time its funding capacity has also grown, and it now offers commercial loans up to a value of $15m, which it provides through its investor-backed ExpressFUND. Short said there were a lot of deals still available and Holden Capital Partners had willing investors. “There are a lot of quality deals in the market and we and our investors have a strong appetite, often there just needs to be more due diligence put in during changing market conditions,” he said. Short has over 10 years of experience in commercial property and finance and was formerly a project partner at East Coast Invest before joining Holden Capital Partners as a consultant in 2020. He stepped into the head of brokerage role for the business late last year. How are your developer clients going in the current market? Share your thoughts in the comments section below. Related stories:

Holden Capital Investments

17 Investments

Holden Capital has made 17 investments. Their latest investment was in BioMimetic Therapeutics as part of their Series C on April 4, 2005.

CBI Logo

Holden Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

4/22/2005

Series C

BioMimetic Therapeutics

$37.51M

No

1/21/2004

Series C

Alpine Access

$4.8M

Yes

9/19/2003

Series B

Customerlink Systems

$3.2M

No

7/24/2003

Series C

Subscribe to see more

$99M

Subscribe to see more

0

5/23/2003

Series B

Subscribe to see more

$99M

Subscribe to see more

0

Date

4/22/2005

1/21/2004

9/19/2003

7/24/2003

5/23/2003

Round

Series C

Series C

Series B

Series C

Series B

Company

BioMimetic Therapeutics

Alpine Access

Customerlink Systems

Subscribe to see more

Subscribe to see more

Amount

$37.51M

$4.8M

$3.2M

$99M

$99M

New?

No

Yes

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

0

0

Holden Capital Portfolio Exits

4 Portfolio Exits

Holden Capital has 4 portfolio exits. Their latest portfolio exit was Customerlink Systems on April 11, 2014.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

4/11/2014

Acquired

$99M

1

8/22/2012

Acquired

Subscribe to see more

$99M

Subscribe to see more

0

5/15/2006

IPO

Subscribe to see more

$99M

Subscribe to see more

0

4/24/2003

Acquired

Subscribe to see more

$99M

Subscribe to see more

0

Date

4/11/2014

8/22/2012

5/15/2006

4/24/2003

Exit

Acquired

Acquired

IPO

Acquired

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

0

0

0

Holden Capital Team

1 Team Member

Holden Capital has 1 team member, including former Managing Partner, Michael Block.

Name

Work History

Title

Status

Michael Block

Confluence Capital Partners

Managing Partner

Former

Name

Michael Block

Work History

Confluence Capital Partners

Title

Managing Partner

Status

Former

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.